Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada

Journal of Critical Care

Volumn 29, Issue 6, 2014, Pages 955-960

  Barletta, Jeffrey F ^a   Kanji, Salmaan ^b,z   MacLaren, Robert ^c,n   Lat, Ishaq ^d   Erstad, Brian L ^e   Bartlett, Brett ^f   Cherry, Dyan ^f   Winegardner, Jim ^g   Forsyth, Lisa ^g   Kast, Jenna ^g   Cadiz, Megan ^g   Natavio, Allycia ^g   Patel, Jignesh ^h   Connor, Kathryn ^h   Groth, Christine ^h   Falvey, Jennifer ^h   Acquisto, Nicole ^h   Dzierba, Amy ⁱ   Patel, Mona ⁱ   Muir, Justin ⁱ   Park, Linda ^j   Hall Zimmerman, Lisa ^a   Faris, Janie ^j   Roberts, Russel ^k   Thomas, Zachariah ^l   Patel, Ruchi ^l   Ahrens, Christine ^m   Gladden, Dustin ^o   Wahby, Krista ^p   Hodgman, Tudy ^q   Kennelly, Caitlin ^r   Esaian, Diana ^r   Papadopoulos, John ^r   Bosse, Laura ^s   Catlin, Jennifer ^t   Bolesta, Scott ^u   Pangrazzi, Mark ^v   Murray, Kyle ^w   Kristeller, Judy ^x   Lizza, Bryan ^y   Maclean, Robert ^z   Farah, Leban ^z   Teng, Jennifer ^aa   Dewhurst, Norman ^aa   Saccucci, Paola ^aa   Schultz, Laura ^aa   Proceviat, Johanna ^aa   Lamarre, Patrice ^ab   Blain, Hugues ^ab   Dion, Jocelyn ^ab   Newman, Paula ^ac   Bhuptani, Pulkit ^ac   Landry, Christine ^ad   Vaillancourt, Lise ^ad   more..

^a MIDWESTERN UNIVERSITY   (United States)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f HonorHealth and the Scottsdale Lincoln Health Network   (United States)

^g Beaumont Hospital Royal Oak   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ Och Spine at New York Presbyterian Hospitals   (United States)

^j DETROIT RECEIVING HOSPITAL   (United States)

^k TUFTS MEDICAL CENTER   (United States)

^l HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ UNIVERSITY OF COLORADO   (United States)

^o Internal Medicine/Cardiology   (United States)

^p HARPER UNIVERSITY HOSPITAL   (United States)

^q NORTHWEST COMMUNITY HOSPITAL   (United States)

^r NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^s Maricopa Integrated Health System   (United States)

^t Avera McKennan   (United States)

^u Regional Hospital of Scranton   (United States)

^v SINAI GRACE HOSPITAL   (United States)

^w Huron Valley Hospital   (United States)

^x Moses Taylor Hospital   (United States)

^y NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^z UNIVERSITY OF OTTAWA   (Canada)

^aa ST MICHAEL'S HOSPITAL   (Canada)

^ab CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^ac KINGSTON GENERAL HOSPITAL   (Canada)

^ad Hopital Montfort Hospital   (Canada)

more..

Author keywords

Epidemiology; Histamine 2 receptor antagonists; Intensive care unit; Proton pump inhibitors; Stress ulcer prophylaxis

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; ANTIULCER AGENT;

ACID SUPPRESSIVE THERAPY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CANADA; CHEMOPROPHYLAXIS; CHEMOTHERAPY; DRUG PREFERENCE; DRUG USE; ENTERAL DRUG ADMINISTRATION; ENTERIC FEEDING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HIGH RISK POPULATION; HUMAN; INAPPROPRIATE PRESCRIBING; INCIDENCE; INTENSIVE CARE UNIT; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PATIENT CODING; PATIENT HISTORY OF CHEMOTHERAPY; PATIENT IDENTIFICATION; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SHOCK; STRESS ULCER; STRESS ULCER PROPHYLAXIS; TREND STUDY; UNITED STATES; AGED; CLINICAL TRIAL; CRITICAL ILLNESS; CROSS-SECTIONAL STUDY; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; PEPTIC ULCER; PSYCHOLOGY; RISK;

ADULT; AGED; ANTI-ULCER AGENTS; CANADA; CRITICAL ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HISTAMINE H2 ANTAGONISTS; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PEPTIC ULCER; PHARMACOEPIDEMIOLOGY; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RISK; RISK FACTORS; UNITED STATES;

EID: 84908145665     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.06.025     Document Type: Article

References (25)

1. Cook D.J., Fuller H.D., Guyatt G.H., et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994, 330:377-381.
2. Barletta J.F., Erstad B.L., Fortune J.B. Stress ulcer prophylaxis in trauma patients. Crit Care 2002, 6:526-530.
3. Barletta J.F., Lat I., Micek S.T., Cohen H., Olsen K.M., Haas C.E. Off-label use of gastrointestinal medications in the intensive care unit. J Intensive Care Med 2013, [Epub ahead of print].
4. Daley R.J., Rebuck J.A., Welage L.S., Rogers F.B. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004, 32:2008-2013.
5. Erstad B.L., Barletta J.F., Jacobi J., Killian A.D., Kramer K.M., Martin S.J. Survey of stress ulcer prophylaxis. Crit Care 1999, 3:145-149.
6. Alhazzani W., Alenezi F., Jaeschke R.Z., Moayyedi P., Cook D.J. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2013, 41:693-705.
7. Barletta J.F., El-Ibiary S.Y., Davis L.E., Nguyen B., Raney C.R. Proton pump inhibitors and the risk for hospital-acquired Clostridium difficile infection. Mayo Clin Proc 2013, 88:1085-1090.
8. Herzig S.J., Howell M.D., Ngo L.H., Marcantonio E.R. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301:2120-2128.
9. Howell M.D., Novack V., Grgurich P., et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010, 170:784-790.
10. Therapeutic A.S.H.P. Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm 1999, 56:347-379.
11. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
12. MacLaren R. A review of stress ulcer prophylaxis. J Pharm Pract 2002, 15:147-157.
13. Marik P.E., Vasu T., Hirani A., Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med 2010, 38:2222-2228.
14. Egol A., Shander A., Kirkland L., et al. Pay for performance in critical care: an executive summary of the position paper by the Society of Critical Care Medicine. Crit Care Med 2009, 37:2625-2631.
15. Farrell C.P., Mercogliano G., Kuntz C.L. Overuse of stress ulcer prophylaxis in the critical care setting and beyond. J Crit Care 2010, 25:214-220.
16. Herzig S.J., Vaughn B.P., Howell M.D., Ngo L.H., Marcantonio E.R. Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding. Arch Intern Med 2011, 171:991-997.
17. Conrad S.A., Gabrielli A., Margolis B., et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005, 33:760-765.
18. Maclaren R., Reynolds P.M., Allen R.R. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014, 174:564-574.
19. Barletta J.F., Sclar D.A. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences. PharmacoEconomics 2014, 32:5-13.
20. MacLaren R., Campbell J. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*. Crit Care Med 2014, 42:809-815.
21. Yang Y.X., Lewis J.D., Epstein S., Metz D.C. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006, 296:2947-2953.
22. Hurt R.T., Frazier T.H., McClave S.A., et al. Stress prophylaxis in intensive care unit patients and the role of enteral nutrition. JPEN J Parenter Enteral Nutr 2012, 36:721-731.
23. Lam N.P., Le P.D., Crawford S.Y., Patel S. National survey of stress ulcer prophylaxis. Crit Care Med 1999, 27:98-103.
24. Preslaski C., MacLaren R., Mueller S., Kiser T., Fish D. A survey of prescriber perceptions about stress ulcer prophylaxis in the ICU. Crit Care Med 2013, 41:A732.
25. Olsen K.M., Devlin J.W. Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients. Aliment Pharmacol Ther 2008, 28:326-333.